建議您使用以下瀏覽器觀看本網站，
以獲得最佳瀏覽效果。
Our team
Ken Cheng
Metagone Biotech Group Founder
- Dongguan Shun Cheng Computer Enteprise Corporation Director of Board
- Solytech Enteprise Corporation President
- Experiences in R&D and manufacturing departments of electronic components industry management for over 30 years
- Biotech investing over 10 years experience
Simon Huang
President/General Manager
- NYIT M.B.A.
- Barits Securities Corporation Researcher
- Solytech Enteprise Corporation Independent President
- Taipei Biotech Association Supervisor
- Professional experiences in clinical trail over 6 years
- Professional experiences (including the experiences of the securities industry and the investment company) in financial industry and capital market for over 20 years.
Da-Wen Lu, Professor, M.D., Ph.D.
Medical Director
- Director, General Ophthalmology Department, Tri-Service General Hospital
- Director, Department of Glaucoma, Tri-Service General Hospital
- Professor, Department of Ophthalmology, National Defense Medical Center
- Chairman, Taiwan association for relief of glaucoma and effective therapy
Cheng-Kuo, Cheng, Associate Professor, M.D.
Medical Director
- Director, Department of ophthalmology and Retina Center of Shin Kong Hospital
- Executive Director, Taiwan Retina Society
- Associate Professor, Department of Medicine, Fu Jen Catholic University
- Director, Department of Ophthalmology, Fu Jen Catholic University
- Adjunct Assistant Professor, Department of Medicine, National Taiwan University
Akaphot Thongmee (Mark), M.D.
Chief Medical Officer
Dr. Mark Thongmee, M.D., MRCP (UK), is a translational research physician trained in Translational Medicine and Early Phase Development from Imperial College London. With over a decade of experience, he has contributed significantly to clinical trials in infectious diseases and oncology across Southeast Asia, including leading community-based trials for HIV and HCV. He has spearheaded numerous research trials and medical initiatives, notably as;
- Global Medical Affairs lead at GPCRO Contract Research Organisation, leading the clinical trial designed and medical monitor for oncology, ophthalmology, COVID-19 infection, and gene therapy.
- Country Medical Director at Amgen and Allergan, he bridged clinical research with strategic medical affairs, enhanced drug accessibility, and implemented health economic outcomes research (HEOR) to support reimbursement strategies.
Amy Chen
Chief Financial Officer & Office of General Affairs, Director
- Royal Roads University M.B.A. in Executive Management
- Wayi International Digital Entertainment Co.,Ltd. Manager
- Professional experiences in financial management and fund allocation for over 25 years.
